Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

153
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
153
Pneumonia IV: Management01:28

Pneumonia IV: Management

297
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
297
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

1.8K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
1.8K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

205
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
205
Pneumothorax-II01:27

Pneumothorax-II

120
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
120
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

212
The pathophysiology of pneumonia involves the following steps:
212

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ERS Congress 2025: highlights from the Pulmonary Vascular Diseases Assembly.

ERJ open research·2026
Same author

Inhaled treprostinil for pulmonary hypertension associated with interstitial lung disease: advances, challenges, and future directions.

Expert review of respiratory medicine·2026
Same author

Does the method matter? Direct fick vs thermodilution in the haemodynamic assessment of pulmonary hypertension.

ESC heart failure·2026
Same author

High-flow nasal oxygen for the relief of persistent dyspnea in adult patients with cancer: A systematic review and meta-analysis.

Palliative medicine·2026
Same author

[Pneumology : what's new in 2025].

Revue medicale suisse·2026
Same author

Delayed Massive Haemoptysis Following EBUS-TBNA Revealing a Pseudoaneurysm of an Ectopic Bronchial Artery: A Rare Complication at the Crossroads of Interventional Pulmonology and Radiology.

Respirology case reports·2025

Related Experiment Video

Updated: Jun 2, 2025

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.2K

[Pneumology : what's new in 2024].

Frédéric Lador1, Pieter-Jan Gijs2, Léon Genecand3

  • 1Faculté de médecine, Université de Genève, 1205 Genève.

Revue Medicale Suisse
|January 15, 2025
PubMed
Summary

2024 innovations advance respiratory disease management, including pulmonary hypertension, COPD, and tuberculosis treatments. New therapies offer personalized medicine and improved patient outcomes.

More Related Videos

Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship
08:25

Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship

Published on: January 8, 2019

9.3K
Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.2K

Related Experiment Videos

Last Updated: Jun 2, 2025

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models
07:56

Evaluating Regional Pulmonary Deposition using Patient-Specific 3D Printed Lung Models

Published on: November 11, 2020

4.2K
Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship
08:25

Combining Volumetric Capnography And Barometric Plethysmography To Measure The Lung Structure-function Relationship

Published on: January 8, 2019

9.3K
Experimental Model to Evaluate Resolution of Pneumonia
09:49

Experimental Model to Evaluate Resolution of Pneumonia

Published on: February 17, 2023

1.2K

Area of Science:

  • Respiratory Medicine
  • Pulmonology
  • Medical Innovations

Context:

  • Management of chronic respiratory diseases like pulmonary hypertension, COPD, and tuberculosis.
  • Emerging trends in personalized medicine for respiratory conditions.

Purpose:

  • To highlight key 2024 innovations in respiratory disease management.
  • To discuss advancements in pulmonary hypertension, COPD, and tuberculosis treatment.

Summary:

  • Introduction of sotatercept for pulmonary arterial hypertension and mediastinal cryobiopsies in Switzerland.
  • Development of biologic therapies for COPD and potential for shortened tuberculosis treatment regimens.
  • Focus on personalized medicine approaches and novel therapeutic options.

Impact:

  • Potential for enhanced patient care and significant clinical benefits.
  • Opening new avenues for treating complex respiratory conditions.
  • Shifting towards more tailored and effective treatment strategies.